The following is a summary of “Kinetics of tick-borne encephalitis virus IgM antibody responses in serum and cerebrospinal ...

IGM Biosciences (NASDAQ:IGMS) is slashing its workforce by 73% and discontinuing development of two of its lead drug ...

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM ...

Charles Schwab Investment Management Inc. lifted its holdings in IGM Biosciences, Inc. (NASDAQ:IGMS – Free Report) by 6.4% in ...

Antibodies are one of the most specific tools for the detection and capture of molecular targets­­. The right antibody can play a key role in revealing the presence, quantity, dynamics, and even ...

This case emphasises the need for early recognition and proper diagnosis of CHIKV infection in patients with acute joint pain ...

The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs ...